Istari Oncology, Inc.
9 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| LUMINOS-103: A Basket Trial of Safety & Efficacy of Lerapolturev With or Without Checkpoint Inhibitors (NCT04690699) | Istari Oncology, Inc. | 2021-08-01 |
| LUMINOS-102: Lerapolturev With or Without Immune Checkpoint Blockade in Advanced PD-1 Refractory Melanoma (NCT04577807) | Istari Oncology, Inc. | 2020-11-17 |
| LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma (NCT04479241) | Istari Oncology, Inc. | 2020-10-21 |
| Examining Bioactivity of PVSRIPO in Invasive Breast Cancer (NCT03564782) | Istari Oncology, Inc. | 2019-06-30 |
| PVSRIPO for Patients With Unresectable Melanoma (NCT03712358) | Istari Oncology, Inc. | 2018-11-26 |
| Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children (NCT03043391) | Istari Oncology, Inc. | 2017-11-07 |
Track Istari Oncology, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.